Smart Pharmacy, Inc. v. Viccari

213 So. 3d 986, 2016 WL 3057379, 2016 Fla. App. LEXIS 8173
CourtDistrict Court of Appeal of Florida
DecidedMay 31, 2016
DocketNo. 1D15-4380
StatusPublished
Cited by3 cases

This text of 213 So. 3d 986 (Smart Pharmacy, Inc. v. Viccari) is published on Counsel Stack Legal Research, covering District Court of Appeal of Florida primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Smart Pharmacy, Inc. v. Viccari, 213 So. 3d 986, 2016 WL 3057379, 2016 Fla. App. LEXIS 8173 (Fla. Ct. App. 2016).

Opinion

WETHERELL, J.

Smart Pharmacy, Inc., appeals the order denying its motion for a temporary injunction against Appellees Damian Viceari and Pensacola Apothecary, Inc. We reverse the order and remand for entry of a temporary injunction because the trial court erroneously concluded that Smart Pharmacy had an adequate remedy at law and that it does not have a substantial likelihood of success on the merits of its claims against Appellees.

Factual and Procedural Background

Smart Pharmacy is a compounding pharmacy that makes and fills prescriptions for specialized medications requiring mixtures of ingredients or doses that are not available in standard, mass-produced, commercially available medications. Smart Pharmacy’s business is dependent upon physicians prescribing its compounded medications to their patients, and as a result, Smart Pharmacy considers its physician referral sources and their prescribing patterns to be trade secrets.

Viccari worked as a sales representative for Smart Pharmacy, and his job was to market Smart Pharmacy’s products and [989]*989services to physicians in the Jacksonville-area market (i.e., Baker, Clay, Duval, Nassau, and St. Johns Counties). During his employment with Smart Pharmacy, Viccari executed a noncompete agreement that, among other things, prohibited him from competing against Smart Pharmacy in the Jacksonville-area market for a period of two years after his employment ended.

Three months after Viccari resigned from Smart Pharmacy, he started working as a sales representative for another compounding pharmacy, Pensacola Apothecary. The work that Viccari performed at Pensacola Apothecary was the same work that he performed at Smart Pharmacy, i.e., marketing his employer’s compounded medications to physicians. Additionally, while working for Pensacola Apothecary, Viccari solicited business from some of the same physicians in the Jacksonville-area market who he solicited while working for Smart Pharmacy.

Shortly after Viccari started working for Pensacola Apothecary, Smart Pharmacy filed suit against Appellees seeking damages and injunctive relief for Viccari’s alleged breach of his noncompete agreement and his and Pensacola Apothecary’s alleged misuse of Smart Pharmacy’s trade secrets. Smart Pharmacy also sought a temporary injunction to enforce the non-compete agreement and enjoin Appellees from engaging in the conduct alleged in the complaint.

The trial court denied the motion for a temporary injunction after an evidentiary hearing. The court reasoned that although the noncompete agreement validly protected Smart Pharmacy’s legitimate business interests in its relationships with referring physicians, Smart Pharmacy had an adequate remedy at law because some of its alleged damages were “quantifiable.” However, the court also found that Smart Pharmacy did not have a substantial likelihood of success on the merits of its claims against Appellees because some of its alleged damages were speculative.

Smart Pharmacy timely appealed the order denying its motion for a temporary injunction to this court. We have jurisdiction to review this nonfinal order pursuant to Florida Rule of Appellate Procedure 9.130(a)(3)(B).

Analysis

In order to obtain a temporary injunction, Smart Pharmacy was required to establish (1) the likelihood of irreparable harm, (2) the unavailability of an adequate remedy at law, (3) a substantial likelihood of success on the merits, and (4) that the injunction will serve the public interest. SunTrust Banks, Inc. v. Cauthon & McGuigan, PLC, 78 So.3d 709, 711 (Fla. 1st DCA 2012). Smart Pharmacy contends that it established each of these elements and, thus, it was error for the trial court not to enter a temporary injunction. We agree.

“The right to prohibit the direct solicitation of existing customers is a legitimate business interest, and a covenant not to compete which includes a non-solicitation clause is breached when a former employee directly solicits customers of his former employer.” Atomic Tattoos, LLC v. Morgan, 45 So.3d 63, 65 (Fla. 2d DCA 2010) (internal quotations and alterations omitted). Here, the record reflects—and Appellees do not dispute—that Viccari violated his noncompete agreement by directly soliciting some of the same physicians in the Jacksonville-area market on behalf of Pensacola Apothecary who he solicited while working as a sales representative for Smart Pharmacy. Additionally, the record reflects that Pensacola Apothecary was complicit in Viccari’s violation of the agreement and benefitted from Viccari’s use of Smart Pharmacy’s trade secrets. Accordingly, contrary to the trial court’s conclu[990]*990sion,1 Smart Pharmacy established a substantial likelihood of success on the merits of its claims against Appellees. See Walsh v. PAW Trucking, Inc., 942 So.2d 446, 448 (Fla. 4th DCA 2006) (“Evidence that an enforceable covenant not to compete was breached will support a trial court’s finding of the likelihood of success on the merits.”).

“The violation of an enforceable restrictive covenant creates a presumption of irreparable injury to the person seeking enforcement of a restrictive covenant.” § 542.335(l)(j), Fla. Stat. To rebut the presumption, the defendant must establish “the absence of an injury.” DePuy Orthopaedics, Inc. v. Waxman, 95 So.3d 928, 939 (Fla. 1st DCA 2012). Here, Smart Pharmacy was entitled to a presumption of irreparable harm based on Viccari’s violation of his noncompete agreement, and the presumption was not rebutted because it was undisputed that Smart Pharmacy lost at least some business to Pensacola Apothecary as a direct result of Viccari’s breach and Pensacola Apothecary’s complicity therein.

Smart Pharmacy does not have an adequate remedy at law for the irreparable harm it has suffered, and may continue to suffer,2 as a result of Appellees’ actions because “monetary damages are difficult to prove with any certainty and ... even if provable, would not adequately compensate for all aspects of the violation of a covenant not to compete.” King v. Jessup, 698 So.2d 339, 340 (Fla. 5th DCA 1997); see also Miller Mech., Inc. v. Ruth, 300 So.2d 11, 12 (Fla.1974) (explaining that in cases involving a violation of a covenant not to compete, “the normal remedy is to grant an injunction ... because of the inherently difficult, although not impossible, task of determining just what damage actually is caused by the employee’s breach of the agreement”). Indeed, this point is reinforced in this case by the trial court’s findings that some of Smart Pharmacy’s alleged damages were “quantifiable” while other al[991]*991leged damages were “speculative.” See Variable Annuity Life Ins. Co. v. Hausinger, 927 So.2d 243, 245 (Fla. 2d DCA 2006) (reversing denial of a temporary injunction even though “money damages were ascertainable to some clients that [the former employee] admittedly solicited” because “the harm presumed under the statute includes the potential damages to [the plaintiffs] longstanding relationships with its customers and the protection of confidential client information”).

Finally, the record reflects that a preliminary injunction would serve the public interest because the trial court found that Smart Pharmacy has a legitimate business interest in protecting its relationships with its referral sources. See Atomic Tattoos,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Data Payment Systems v. Caso
253 So. 3d 53 (District Court of Appeal of Florida, 2018)
Ansaarie v. First Coast Cardiovascular Inst., P.A.
252 So. 3d 287 (District Court of Appeal of Florida, 2018)
PREMIER COMPOUNDING PHARMACY, INC. v. ERIC LARSON
250 So. 3d 94 (District Court of Appeal of Florida, 2018)

Cite This Page — Counsel Stack

Bluebook (online)
213 So. 3d 986, 2016 WL 3057379, 2016 Fla. App. LEXIS 8173, Counsel Stack Legal Research, https://law.counselstack.com/opinion/smart-pharmacy-inc-v-viccari-fladistctapp-2016.